Important Contacts for Health Biotechnology in China from Prof. Dr. Türkez

Prof. Dr. Hasan Türkez held comprehensive contacts to implement joint projects in the fields of health biotechnology, biopharmaceutical drugs, and clinical studies with Zhengzhou University and various research institutions in China.

Zhengzhou University Visit and Clinical Capacity

At Zhengzhou University, one of the prominent stops of the China program, cooperation opportunities in the fields of health and research were discussed in detail. The university draws attention with its 14 hospitals and a clinical capacity of approximately 40,000 beds.

Joint Projects and Research Topics

Prof. Dr. Hasan Türkez announced that joint projects have been initiated with the teams of Prof. Dr. Yongjun Wei and Prof. Dr. Jinjin Shi under the headings of health biotechnology, biopharmaceutical drugs, innovative treatment platforms, translational research, and clinical studies.

Interinstitutional R&D and Commercialization Talks

Within the scope of the China program, meetings were held with representatives of various universities, research centers, and biotechnology organizations. During the contacts, joint R&D activities, technology development, and commercialization opportunities were evaluated.

Scientific Objectives and Global Positioning

It was stated that the main objective of the contacts is to transform scientific discoveries into technology, technology into clinical studies, and ultimately into new treatments that will reach patients. The studies aim to contribute to Turkey's capacity.